New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) Cagrilintide– Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) US$ 25.06 Min. order: 1 piece ★★★★★ 4.3 (154 reviews) Sold : Login>>
CagriSema (Cagrilintide–Semaglutide) in Adults with Overweight or Obesity and Type 2 Diabetes US$ 26.89 Min. order: 1 piece ★★★★★ 4.8 (195 reviews) Sold : Login>>
Is BPC-157 Banned? Oral vs. Injectable Forms Explained US$ 25.01 Min. order: 1 piece ★★★★★ 4.6 (297 reviews) Sold : Login>>
Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta-Analysis US$ 20.45 Min. order: 1 piece ★★★★★ 4.0 (299 reviews) Sold : Login>>
Cagrilintide 10mg, Semaglutide 10mg Blend US$ 26.16 Min. order: 1 piece ★★★★★ 4.2 (149 reviews) Sold : Login>>